News on De_Lange_Syndrome from BioPortfolio.com http://www.BioPortfolio.com Consolidated De_Lange_Syndrome news from BioPortfolio.com Wed, 10 Feb 2010 05:41:52 GMT en Bacteremia in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Epidemiology, Risk Factors, and Predictive Value of Skin Cultureshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961677&HITNO=0&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961677&THISHREF=http://c.moreover.com/click/here.pl%3fz2496877301%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961677&HITNO=0&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961677&THISHREF=http://c.moreover.com/click/here.pl%3fz2496877301%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeich's Genous(TM) Bio-engineered Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954523&HITNO=1&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954523&THISHREF=http://c.moreover.com/click/here.pl%3fz2492808567%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954523&HITNO=1&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954523&THISHREF=http://c.moreover.com/click/here.pl%3fz2492808567%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTickerTech.com: Hyperimmunoglobulin E Syndrome Genetics: New hyperimmunoglobulin e syndrome genetics findings from University of Nijmegen, Department of Medicine publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3911342&HITNO=2&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3911342&THISHREF=http://c.moreover.com/click/here.pl%3fz2469521675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3911342&HITNO=2&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3911342&THISHREF=http://c.moreover.com/click/here.pl%3fz2469521675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: EyeGate Pharma raises $22.6m for dry eye treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886064&HITNO=3&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886064&THISHREF=http://c.moreover.com/click/here.pl%3fz2457619739%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886064&HITNO=3&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886064&THISHREF=http://c.moreover.com/click/here.pl%3fz2457619739%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAltAssets.net: EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3883599&HITNO=4&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3883599&THISHREF=http://c.moreover.com/click/here.pl%3fz2455959309%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3883599&HITNO=4&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3883599&THISHREF=http://c.moreover.com/click/here.pl%3fz2455959309%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMediLexicon: EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3883471&HITNO=5&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3883471&THISHREF=http://c.moreover.com/click/here.pl%3fz2455750635%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3883471&HITNO=5&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3883471&THISHREF=http://c.moreover.com/click/here.pl%3fz2455750635%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndromehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876424&HITNO=6&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876424&THISHREF=http://c.moreover.com/click/here.pl%3fz2451523684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876424&HITNO=6&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876424&THISHREF=http://c.moreover.com/click/here.pl%3fz2451523684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndromehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876379&HITNO=7&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876379&THISHREF=http://c.moreover.com/click/here.pl%3fz2451512927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876379&HITNO=7&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876379&THISHREF=http://c.moreover.com/click/here.pl%3fz2451512927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880091&HITNO=8&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880091&THISHREF=http://c.moreover.com/click/here.pl%3fz2453171780%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880091&HITNO=8&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880091&THISHREF=http://c.moreover.com/click/here.pl%3fz2453171780%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880052&HITNO=9&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880052&THISHREF=http://c.moreover.com/click/here.pl%3fz2453149998%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880052&HITNO=9&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880052&THISHREF=http://c.moreover.com/click/here.pl%3fz2453149998%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: ::: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Shttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3879468&HITNO=10&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3879468&THISHREF=http://c.moreover.com/click/here.pl%3fz2452854409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3879468&HITNO=10&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3879468&THISHREF=http://c.moreover.com/click/here.pl%3fz2452854409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotech Intelligence: EyeGate Pharma Secures $http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878058&HITNO=11&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878058&THISHREF=http://c.moreover.com/click/here.pl%3fz2452149796%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878058&HITNO=11&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878058&THISHREF=http://c.moreover.com/click/here.pl%3fz2452149796%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: EyeGate Pharma Raises $22.6 Millionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877696&HITNO=12&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877696&THISHREF=http://c.moreover.com/click/here.pl%3fz2452021995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877696&HITNO=12&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877696&THISHREF=http://c.moreover.com/click/here.pl%3fz2452021995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPrivate Equity HUB: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876619&HITNO=13&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876619&THISHREF=http://c.moreover.com/click/here.pl%3fz2451622775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876619&HITNO=13&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876619&THISHREF=http://c.moreover.com/click/here.pl%3fz2451622775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876587&HITNO=14&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876587&THISHREF=http://c.moreover.com/click/here.pl%3fz2451607048%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876587&HITNO=14&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=De_Lange_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876587&THISHREF=http://c.moreover.com/click/here.pl%3fz2451607048%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: